Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Biochimica Et Biophysica Acta
|
March 19, 2013
A practical data processing workflow for multi-OMICS projects
Michael Kohl, Dominik A Megger, Martin Trippler, et al.
Journal of Clinical Pathology
|
January 6, 2016
Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions
Stefanie Bertram, Juliet Padden, Julia Kälsch, et al.
Elife
|
July 3, 2025
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
Fabienne Maassen, Vu Thuy Khanh Le-Trilling, Luisa Betke, et al.
JMIR Research Protocols
|
May 25, 2026
AI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Katharina Rump, Hartmuth Nowak, Martin Eisenacher, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, et al.
International Journal of Cancer
|
June 11, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
Anita Csizmarik, Dávid Keresztes, Nikolett Nagy, et al.
Antiviral Research
|
January 14, 2014
Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
Catherine I Real, Dominik A Megger, Barbara Sitek, et al.
Prostate Cancer and Prostatic Diseases
|
August 26, 2023
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, et al.
Virchows Archiv : an International Journal of Pathology
|
March 31, 2017
Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels
Julia Kälsch, Juliet Padden, Stefanie Bertram, et al.
Molecular & Cellular Proteomics : MCP
|
July 19, 2014
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma
Juliet Padden, Dominik A Megger, Thilo Bracht, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Biochimica Et Biophysica Acta
|
March 19, 2013
A practical data processing workflow for multi-OMICS projects
Michael Kohl, Dominik A Megger, Martin Trippler, et al.
Journal of Clinical Pathology
|
January 6, 2016
Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions
Stefanie Bertram, Juliet Padden, Julia Kälsch, et al.
Elife
|
July 3, 2025
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
Fabienne Maassen, Vu Thuy Khanh Le-Trilling, Luisa Betke, et al.
JMIR Research Protocols
|
May 25, 2026
AI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Katharina Rump, Hartmuth Nowak, Martin Eisenacher, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, et al.
International Journal of Cancer
|
June 11, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
Anita Csizmarik, Dávid Keresztes, Nikolett Nagy, et al.
Antiviral Research
|
January 14, 2014
Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
Catherine I Real, Dominik A Megger, Barbara Sitek, et al.
Prostate Cancer and Prostatic Diseases
|
August 26, 2023
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, et al.
Virchows Archiv : an International Journal of Pathology
|
March 31, 2017
Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels
Julia Kälsch, Juliet Padden, Stefanie Bertram, et al.
Molecular & Cellular Proteomics : MCP
|
July 19, 2014
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma
Juliet Padden, Dominik A Megger, Thilo Bracht, et al.
Page
of 14